Worth reading
69In focus
Scored from 2 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
512900
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of the Series 16 Stock Acquisition Rights issued through a third-party allotment (with an option to revise the exercise price)
Who receives how much512,900Shares
512,900 newly issued shares
Cantor Fitzgerald Europe (issued on 26 December 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
Terms of the stock acquisition rights
Exercise price
The exercise price during the target month was ¥764 per share. Whether a revision clause applies and the floor for any revision: Not disclosed
Number of Stock Acquisition Rights
Total issued: 6,515 stock acquisition rights. Unexercised at the end of the target month: 1,043
Most recent equity financing
Timing 26 December 2025 / Type Issuance of the 16th Series of Stock Acquisition Rights (with an Option to Revise the Exercise Price) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of the Series 16 Stock Acquisition Rights issued through a third-party allotment (with an option to revise the exercise price) |
| Number of shares to be issued or disposed of | 512,900 newly issued shares |
| Intended allottee | Cantor Fitzgerald Europe (issued on 26 December 2025) |
| Total number of issued shares | 8,394,800 shares (as of the end of the month preceding the target month, including 61,508 treasury shares) → Not disclosed |
| Exercise price | The exercise price during the target month was ¥764 per share. Whether a revision clause applies and the floor for any revision: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 6,515 stock acquisition rights. Unexercised at the end of the target month: 1,043 |
| Most recent equity financing | Timing 26 December 2025 / Type Issuance of the 16th Series of Stock Acquisition Rights (with an Option to Revise the Exercise Price) / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This is a report on the monthly exercise status, and the company has provided no explanation of the reasons for the exercises.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.